公司概覽
業務類別 Packaged Foods
業務概覽 Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercializationof dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
公司地址 6550 South Millrock Drive, Suite G50, Salt Lake City, UT, USA, 84121
電話號碼 +1 801 676-9695
傳真號碼 --
公司網頁 https://www.clene.com
員工數量 76
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Morgan R. Brown Chief Financial Officer and Principal Accounting Officer 美元 292.58K 10/04/2026
Mr. Robert Etherington President, Chief Executive Officer and Director 美元 508.76K 10/04/2026
Mr. Mark Mortenson Chief Science Officer 美元 412.02K 10/04/2026
 
董事會成員
董事會 職務 更新日期
Mr. David J. Matlin Chairman of the Board 10/04/2026
Mr. Robert Etherington President, Chief Executive Officer and Director 10/04/2026
Mr. Shalom Jacobovitz Independent Director 10/04/2026
Ms. Alison H. Mosca Independent Director 10/04/2026
Mr. Jonathon T. Gay Independent Director 10/04/2026
Mr. Reed Neil Wilcox Independent Director 10/04/2026
Dr. Vallerie V. McLaughlin, M.D. Independent Director 10/04/2026
Dr. Arjun Desai, M.D. Independent Director 10/04/2026
Professor Matthew Kiernan, PhD Independent Director 10/04/2026
 
所屬ETF (更新日期: 11/07/2026 04:28)
代號 名稱 佔比% 持有日期
IWCiShares Micro-Cap ETF0.20%30/06/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.